Biol Trace Elem Res 24:109117 Mischley LK, Conley KE, Shankland EG, Kavanagh TJ, Rosenfeld ME, Duda JE, White CC, Wilbur TK, De La Torre PU, Padowski JM (2016) Central nervous system uptake of intranasal glutathione in Parkinson's disease
The professional obligations of those administering it are far clearer and enforceable. If [medical professionals] provide treatments that are not supported by a responsible body of medical opinion, or fail to obtain properly informed consent, they may be exposed to clinical negligence claims Mr Reissner noted that, The General Medical Council may interest itself in whether [a healthcare provider] can be satisfied that there is sufficient evidence of the use of peptides for a clinical purpose
Protocol design for combination studies should be based on mechanistic rationale and reviewed against available pharmacological data
None of the four peptides is an FDA-approved drug, and none of the blends is approved for any use